PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.

Adding PET/CT to standard diagnostic workup in suspected pancreatic cancer significantly improved relative sensitivity and specificity, as well as significantly influencing the staging and management of patients, and was highly likely to be cost-effective for the NHS.

http://ift.tt/2Bdq1WT